Sunitinib (SU) vs placebo for treatment of progressive, well-differentiated pancreatic islet cell tumours: results of a phase III, randomised, double-blind trial

Raoul, J. L.; Borbath, Ivan; Niccoli, P.; Bang, Y. J.; Lombard-Bohas, C.; Metrakos, P.; Vinik, A.; Lu, D. R.; Blanckmeister, C.; Raymond, E.

Sunitinib (SU) vs placebo for treatment of progressive, well-differentiated pancreatic islet cell tumours: results of a phase III, randomised, double-blind trial

Raoul, J. L.

;

Borbath, Ivan

;

Niccoli, P.

;

Bang, Y. J.

;

Raymond, E.

;et.al.

(2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology — Location: Berlin (Germany) (20.September.2009)

Files

No attached file found for this publication.

Details

Authors

Raoul, J. L.
Author
Borbath, IvanUCLouvain
Author
Niccoli, P.
Author
Bang, Y. J.
Author
Raymond, E.
Author

Affiliations

Citations

APA
Chicago
FWB

Raoul, J. L., Borbath, I., Niccoli, P., Bang, Y. J., Lombard-Bohas, C., Metrakos, P., Vinik, A., Lu, D. R., Blanckmeister, C., & Raymond, E. (2009). Sunitinib (SU) vs placebo for treatment of progressive, well-differentiated pancreatic islet cell tumours: results of a phase III, randomised, double-blind trial. EJC - Supplements, 7(2), 361. https://hdl.handle.net/2078.5/83854 (Original work published 2009)